A relationship between VEGF renal disturbances and glomerular microangiopathic injury is further supported by data on systemic anti-VEGF therapy in six patients, which induced TMA-like glomerulopathy. The gene discussed is VEGFA; the disease is lipoprotein glomerulopathy.